IDEXX LABORATORIES INC /DE
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
Mailing Address ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
Phone 2075560300
Fiscal Year End 1231
EIN 010393723
Financial Overview
FY2024
$887.87M
Net Income
$1.78B
Total Liabilities
$1.60B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
| 8-K Current report of material events | November 13, 2025 | View on SEC |
| 4 Insider stock transaction report | November 10, 2025 | View on SEC |
| 8-K Current report of material events | November 3, 2025 | View on SEC |
| 4 Insider stock transaction report | November 3, 2025 | View on SEC |
Insider Trading
STRONG SELL 1 insiders
8 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
VOLITIONRX LTD
VNRX In Vitro & In Vivo Diagnostic Substances
NEOGEN CORP
NEOG In Vitro & In Vivo Diagnostic Substances
Intellia Therapeutics, Inc.
NTLA In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.